glp-1 drugs and muscle loss do glp 1 cause Using receptor agonists for weight reduction in Why GLP-1 Drugs Alone Aren't

Results The study consisted of 150 patients, with 73 GLP-1 RA users in the experimental group and 77 non-users in the control group

Supports overall daily wellness

Ozempic alternatives in the GLP-1 family offer effective weight loss pathways

The World Obesity Atlas 2024 reports over 1.5 billion projected cases by 2035, highlighting its growing threat among pediatric and adult populations globally

Ozempic and other GLP-1 receptor agonists can increase insulin secretion, suppress glucagon release, slow digestion, and more

Our blog series on GLP-1 agonists for weight loss is aimed at unpacking the science behind this new frontier in weight management, presenting a detailed overview of how they work, their efficacy, and their role in a holistic approach to health and wellness.